PanTher Therapeutics
2 known investors
PanTher develops targeted cancer therapeutics that deliver drugs directly to tumor sites at high concentrations over extended periods, aiming to improve clinical outcomes while reducing side effects. The platform is designed to be applicable across multiple therapeutic types for oncology treatment.
BiotechMedical Devices
Founders & leadership
LI
Laura IndolfiChief Executive Officer and Co-Founder
Investors · 2
In the news
- PanTher Therapeutics - 2025 Company Profile, Team, Funding, Competitors & Financials - Tracxntracxn.com · 2021
- PanTher Therapeutics - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- Cambridge Massachusetts based PanTher Therapeutics is raising $7,334,474.00 in New Equity Investment. - intelligence360intelligence360.news · 2021
- PanTHer Therapeutics Closes $5.4M in Series A Funding - FinSMEsfinsmes.com · 2021
- PanTher Therapeutics Closes Oversubscribed $5.4M Series A Round, Expands Board of Directors, As Company Prepares to Initiate First Clinical Trial of Novel Localized Treatment of Pancreatic Cancerbusinesswire.com · 2021